← Back to Clinical Trials
Recruiting NCT07417826

NCT07417826 Cognitive-Behavioral and Digital Therapy for Suicide Risk in Eating Disorders

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07417826
Status Recruiting
Phase
Sponsor Universitat Autonoma de Barcelona
Condition Eating Disorders
Study Type INTERVENTIONAL
Enrollment 150 participants
Start Date 2025-10-22
Primary Completion 2028-10

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Cognitive Behavioural Therapy (CBT)Cognitive Behavioural Therapy (CBT) + Digital Therapy (DT)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 150 participants in total. It began in 2025-10-22 with a primary completion date of 2028-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to determine if adding a digital intervention to standard cognitive-behavioral therapy (CBT) is more effective in preventing suicide risk and reducing eating disorder symptoms. Participants will be women between 18 and 65 years old who have recently experienced suicidal ideation or attempts. One group will receive standard group therapy, while the other will receive group therapy plus a mobile application and digital monitoring devices. The goal is to see if digital tools can improve clinical outcomes and safety for patients.

Eligibility Criteria

Inclusion Criteria: * Gender: Female. * Age between 18 and 65 years old. * Clinically stable and able to provide written informed consent. * Subjects included in the "Suicide Risk Code" (Codi Risc Suïcidi - CRS) program due to recent suicidal ideation or suicide attempts. * Patients with a diagnosis of an Eating Disorder (ED). Exclusion Criteria: * Presence of intellectual disability or cognitive impairment that prevents understanding the therapy or the study requirements. * Diagnosis of Bipolar Disorder or any Psychotic Disorder. * Current active substance abuse or dependence. * Any medical condition that, in the investigator's opinion, makes participation unsafe or unfeasible.

Frequently Asked Questions

Who can join the NCT07417826 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 65 Years, studying Eating Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07417826 currently recruiting?

Yes, NCT07417826 is actively recruiting participants. Visit ClinicalTrials.gov or contact Universitat Autonoma de Barcelona to inquire about joining.

Where is the NCT07417826 trial being conducted?

This trial is being conducted at Sabadell, Spain.

Who is sponsoring the NCT07417826 clinical trial?

NCT07417826 is sponsored by Universitat Autonoma de Barcelona. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology